Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,033.60 INR | +0.53% |
|
+4.50% | +5.10% |
Apr. 03 | Alivus Life Sciences Says USFDA Issues EIR With VAI Status For Ankleshwar Facility | RE |
Apr. 02 | Alivus Life Sciences Enters Agreement With Torrent Urja 19 | RE |
Chart calendar Alivus Life Sciences Limited
925d437f.ZwRoAl2kmAUULO3MepBKw6g6RByvsmtLPSRsDa6FE_Q.OE8qdwni9m9AQJ6vC8IFp-p2aSyYnw59SU0cX9SxK59TQwtwNtDJfFgZhg~b146b6ae60087f4df7d1a5a1a01dcf69
Upcoming events on Alivus Life Sciences Limited
Past events on Alivus Life Sciences Limited
2025-04-23 | Q4 2025 Earnings Release (Projected) |
2025-03-05 | Investor Meeting - Citi Research |
2025-02-26 | Investor Meeting - Polar Capital |
2025-02-09 | Investor Meeting - Baroda BNP |
2025-02-04 | Investor Meeting - Catamaran |
2025-02-02 | Investor Meeting - Unique AMC |
2025-01-23 05:30 am | Q3 2025 Earnings Call |
2025-01-23 03:53 am | Q3 2025 Earnings Release |
2024-11-27 | Investor Meeting - Bajaj AMC |
2024-11-27 | Investor Meeting - Buoyant Capital |
2024-11-27 | Investor Meeting - Star Union Dai-ichi Life Insurance |
2024-11-26 | Investor Meeting - Tata Asset Management |
2024-10-30 | Investor Meeting - Julius Baer |
2024-10-29 | Investor Meeting - Kotak Securities |
2024-10-24 11:00 pm | Q2 2025 Earnings Call |
2024-10-24 08:57 am | Q2 2025 Earnings Release |
2024-09-25 05:30 am | Annual General Meeting |
2024-09-22 | DAM Capital Pharmaceutical Investor Conference |
2024-09-18 | Kotak Healthcare Forum |
2024-09-08 | Investor Meeting - Old Bridge Capital |
Past dividends on Alivus Life Sciences Limited
2023-10-16 | Interim Payment 22.5 INR |
2023-03-23 | Interim Payment 21 INR |
2022-09-14 | Final Payment 10.5 INR |
2021-11-21 | Interim Payment 10.5 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 21 379 21 326 0.25% | 21 612 20 860 3.61% | 22 832 23 913 -4.52% | 24 061 | 28 104 | 32 103 |
EBITDA Million INR | Released Forecast Spread | 6 308 6 205 1.66% | 6 423 5 875 9.33% | 6 742 7 353 -8.31% | 6 811 | 8 537 | 10 065 |
EBIT Million INR | Released Forecast Spread | 5 929 5 790 2.4% | 6 002 5 514 8.85% | 6 208 6 999 -11.3% | 6 334 | 8 012 | 9 555 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 5 649 5 611 0.68% | 6 286 5 749 9.35% | 6 313 7 057 -10.54% | 6 430 | 8 133 | 9 640 |
Net income Million INR | Released Forecast Spread | 4 187 4 132 1.33% | 4 670 4 264 9.51% | 4 709 5 213 -9.66% | 4 796 | 6 628 | 7 888 |
EPS INR | Released Forecast Spread | 35,6 33,7 5.71% | 38,1 34,8 9.61% | 38,4 42,5 -9.63% | 39,2 | 47,9 | 56,4 |
Announcement Date | 20/04/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 5 093 5 275 -3.45% | 5 407 5 268 2.64% | 6 213 5 486 13.26% | 5 785 5 842 -0.98% | 5 954 5 980 -0.44% | 5 728 6 025 -4.93% | 5 366 6 071 -11.61% | 5 886 5 760 2.19% | 5 781 | 6 189 | 6 235 |
EBITDA Million INR | Released Forecast Spread | 1 436 1 446 -0.66% | 1 455 1 467 -0.85% | 2 064 1 536 34.39% | 1 932 1 705 13.29% | 1 671 2 012 -16.96% | 1 726 1 693 1.92% | 1 414 1 702 -16.87% | 1 595 1 736 -8.13% | 1 719 | 1 744 | 1 757 |
EBIT Million INR | Released Forecast Spread | 1 437 1 588 -9.49% | 1 413 1 528 -7.55% | 1 949 1 503 29.66% | 1 824 1 643 11% | 1 593 1 947 -18.17% | 1 269 1 708 -25.7% | 1 451 1 432 1.33% | 1 618 | 1 627 | 1 580 | |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 820 1 580 15.19% | 1 297 1 729 -25% | 1 502 1 464 2.62% | 1 645 | 1 654 | 1 655 | |||||
Net income Million INR | Released Forecast Spread | 1 069 1 039 2.87% | 1 050 1 087 -3.41% | 1 464 1 087 34.64% | 1 355 1 201 12.83% | 1 187 1 419 -16.32% | 1 188 1 182 0.48% | 979 1 176 -16.68% | 1 115 1 210 -7.83% | 1 134 | 1 208 | 1 249 |
EPS INR | Released Forecast Spread | 11,1 9,60 15.1% | 7,97 10,4 -23.37% | 9,08 9,00 0.89% | 10,0 | 10,0 | 10,0 | |||||
Announcement Date | 21/10/22 | 27/01/23 | 27/04/23 | 21/07/23 | 20/10/23 | 23/01/24 | 25/04/24 | 25/07/24 | - | - | - |
More events
Past sector events for Alivus Life Sciences Limited
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALIVUS Stock
- Calendar Alivus Life Sciences Limited
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national